are able to reprogram tumor cells, turning them into functional cDC1s, which are more effective than other DC subtypes at cross-presenting antigens and inducing antigen-specific T cell responses.

(2) These cells are activated using anti-CD3/CD28 antibodies to stimulate their proliferation. (3) Genetic modification of the T cells is performed by inserting the CAR gene, enabling them to ...